WallStSmart
PMN

ProMIS Neurosciences Inc.

NASDAQ: PMN · HEALTHCARE · BIOTECHNOLOGY

$11.15
+2.76% today

Updated 2026-04-29

Market cap
$99.99M
P/E ratio
P/S ratio
4,016.22x
EPS (TTM)
$-22.61
Dividend yield
52W range
$6 – $40
Volume
0.0M

ProMIS Neurosciences Inc. (PMN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320152016201720182019202020212022202320242025
Operating cash flow$-1.32M$-2.94M$-5.40M$-3.27M$-3.96M$-2.31M$-2.34M$-1.97M$-1.63M$-1.13M$-1.89M$-4.53M$-6.35M$-6.09M$-4.35M$-9.44M$-17.03M$-10.84M$-27.18M$-28.12B
Capital expenditures$82631.00$181514.00$493285.00$89709.00$11374.00$21732.00$4643.00$1249.00$0.00$0.00$0.00$0.00$108666.00$108666.00$108666.00$6124.00$1981.00$0.00$0.00$0.00
Depreciation
Stock-based comp$859575.00$960728.00$528887.00$194773.00$70783.00$520495.00$401564.00$425252.00$552112.00$789210.00$647394.00$414515.00$515629.00$487630.00$271542.00$825808.00$857.63M
Free cash flow$-1.41M$-3.13M$-5.90M$-3.36M$-3.97M$-2.33M$-2.34M$-1.97M$-1.63M$-1.13M$-1.89M$-4.53M$-6.45M$-6.20M$-4.46M$-9.45M$-17.04M$-10.84M$-27.18M$-28.12B
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash